Healthcare provider profile · identity verified

Riley J Torreano, MD

Family Practice · MARQUETTE, MI · NPI 1699125377

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	623	179
Lisinopril	Lisinopril	419	122
Amlodipine Besylate	Amlodipine Besylate	383	101
Losartan Potassium	Losartan Potassium	378	107
Metoprolol Succinate	Metoprolol Succinate	374	102
Levothyroxine Sodium	Levothyroxine Sodium	324	92
Omeprazole	Omeprazole	296	90
Hydrochlorothiazide	Hydrochlorothiazide	277	83
Metformin Hcl	Metformin Hcl	250	71
Eliquis	Apixaban	227	36
Simvastatin	Simvastatin	227	66
Furosemide	Furosemide	222	58
Tamsulosin Hcl	Tamsulosin Hcl	218	58
Metoprolol Tartrate	Metoprolol Tartrate	176	47
Jardiance	Empagliflozin	169	39
Sertraline Hcl	Sertraline Hcl	159	36
Allopurinol	Allopurinol	118	34
Gabapentin	Gabapentin	118	23
Famotidine	Famotidine	111	26
Xarelto	Rivaroxaban	107	26
Spironolactone	Spironolactone	106	25
Rosuvastatin Calcium	Rosuvastatin Calcium	105	25
Citalopram Hbr	Citalopram Hydrobromide	99	20
Pravastatin Sodium	Pravastatin Sodium	99	31
Amitriptyline Hcl	Amitriptyline Hcl	94	27
Clopidogrel	Clopidogrel Bisulfate	90	29
Carvedilol	Carvedilol	88	19
Duloxetine Hcl	Duloxetine Hcl	88	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	87	24
Atenolol	Atenolol	84	25
Potassium Chloride	Potassium Chloride	84	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	21
Finasteride	Finasteride	80	24
Metformin Hcl Er	Metformin Hcl	77	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	73	21
Albuterol Sulfate Hfa	Albuterol Sulfate	71	36
Enalapril Maleate	Enalapril Maleate	71	18
Meloxicam	Meloxicam	68	21
Fluoxetine Hcl	Fluoxetine Hcl	67	19
Pantoprazole Sodium	Pantoprazole Sodium	66	17
Glimepiride	Glimepiride	63	20
Prednisone	Prednisone	63	27
Mirtazapine	Mirtazapine	58	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	15
Montelukast Sodium	Montelukast Sodium	52	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	17
Synthroid	Levothyroxine Sodium	51	17
Ozempic	Semaglutide	49	15
Buspirone Hcl	Buspirone Hcl	48	13
Nitroglycerin	Nitroglycerin	48	21
Alendronate Sodium	Alendronate Sodium	47	16
Mounjaro	Tirzepatide	47	suppressed
Fluticasone Propionate	Fluticasone Propionate	46	21
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	14
Pregabalin	Pregabalin	41	suppressed
Bumetanide	Bumetanide	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Breo Ellipta	Fluticasone/Vilanterol	39	suppressed
Donepezil Hcl	Donepezil Hcl	39	suppressed
Primidone	Primidone	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	13
Trazodone Hcl	Trazodone Hcl	37	17
Escitalopram Oxalate	Escitalopram Oxalate	36	11
Lamotrigine	Lamotrigine	36	suppressed
Terazosin Hcl	Terazosin Hcl	36	suppressed
Nabumetone	Nabumetone	35	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	32	12
Trulicity	Dulaglutide	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Januvia	Sitagliptin Phosphate	27	11
Lovastatin	Lovastatin	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Insulin Lispro	Insulin Lispro	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Humalog	Insulin Lispro	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Clobetasol Propionate	Clobetasol Propionate	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Nuplazid	Pimavanserin Tartrate	23	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Alprazolam	Alprazolam	20	13
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Lacosamide	Lacosamide	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Nifedipine Er	Nifedipine	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Acetazolamide	Acetazolamide	15	suppressed
Colchicine	Colchicine	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Naproxen	Naproxen	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Nystatin	Nystatin	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Anastrozole	Anastrozole	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Neupro	Rotigotine	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Niacin Er	Niacin	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error